Company Overview
- Headquarters
- 8 Davis Drive, Suite 220, Durham NC
- Website
- opusgtx.com
- Employees
- 17
- Founded in
- 2021
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$10B
Who is Opus Genetics
Opus Genetics is a clinical-stage gene therapy company headquartered in Durham, North Carolina. The company is privately held and employs 17 individuals. Opus Genetics specializes in developing innovative treatments for inherited retinal diseases. Opus Genetics focuses on gene therapy programs for a range of inherited retinal diseases. Their approach combines deep understanding of patient needs with a portfolio of wholly owned programs. The company is dedicated to delivering groundbreaking therapies to patients suffering from these debilitating conditions. Opus Genetics stands out due to its unique model and unwavering commitment to patient needs. Backed by the RD Fund, the venture arm of Foundation Fighting Blindness, Opus Genetics benefits from a strong partnership dedicated to advancing research and treatment options for inherited retinal diseases. For more information about Opus Genetics and their gene therapy programs, please visit their website at opusgtx.com.
Company Leadership
Companies Similar to Opus Genetics
Analyze industry trends and opportunities by examining competitors and companies comparable to Opus Genetics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 18 | Arizona City, AZ | 1998 | |
| 10M | 9 | San Diego, CA | ||
| 10M | 6 | Campbell, CA | 2011 | |
| 10M | 2 | Torrington, WY | ||
| 10M | 1 | San Diego, CA | 2016 |